Ghana FDA approves first locally manufactured oncology drug
The Food and Drugs Authority has granted marketing authorisation to the first oncology medication manufactured entirely in Ghana.
The Food and Drugs Authority (FDA) has granted full marketing authorisation to the first oncology medication manufactured entirely in Ghana, a landmark for the country's pharmaceutical manufacturing sector.
FDA CEO Delese Mimi Darko said the drug — an oral chemotherapy agent for chronic myeloid leukaemia — had passed rigorous quality testing equivalent to international standards.
The manufacturer, Kinapharma Limited, invested over $12 million in upgrading its Accra facility to WHO GMP standards.
Related stories
Health
Edo Hospital Acquires IVF Equipment, Expands Access to Fertility Treatment in South-South
An Edo State hospital has acquired advanced IVF equipment, significantly expanding access to assisted reproductive technology for couples struggling with infertility in the South-South region.
Health
World Brain Day: One Nigerian Suffers Stroke Every Minute, Neurologists Warn
Nigerian neurologists have warned that at least one Nigerian develops a stroke every minute, calling for urgent government action on World Brain Day to address the country's crippling shortage of specialists, infrastructure, and diagnostic tools.
Health
Niger State Battles Mysterious Infectious Disease Outbreak, Records One Death
Authorities in Niger State, Nigeria, are responding to an infectious‑disease outbreak that has left at least one person dead and several others hospitalised in affected communities, with health officials working alongside national agencies to identify the cause, contain the spread and reassure residents.
Health
WHO Warns Poor Access to Hepatitis Diagnosis and Treatment Is Driving Dangerous Surge in Africa
A new WHO‑linked analysis highlighted in ThisDay reports that Africa is witnessing a worrying surge in hepatitis B and C infections and deaths, largely because millions still cannot access timely testing, vaccination or life‑saving antiviral treatment, despite the availability of highly effective tools
Comments (0)
Leave a comment
All comments are moderated before publishing. Your email is never published.